Analyst firms · Leerink Partners · PLRX

Leerink Partners PLRX price target and rating history

Pliant Therapeutics Inc. (PLRX) · Health Care

Leerink Partners rates Pliant Therapeutics Inc. (PLRX) Market Perform with a $33 price target, as of its latest action on Mar 3, 2025. It has published 3 rating actions on PLRX since July 2022, including 0 upgrades and 1 downgrade.

Current rating
Market Perform
Price target
$33
Median target, all firms
Too few
Actions on PLRX
3

Leerink Partners price target on PLRX

$36$33$302023202420252026
Leerink Partners price target on PLRX, each point a stated target, July 2022 to September 2024.

Every Leerink Partners rating on PLRX

Questions about Leerink Partners and PLRX

What is Leerink Partners's price target for PLRX?
Leerink Partners's latest stated price target for Pliant Therapeutics Inc. (PLRX) is $33, from its action on Sep 9, 2024.
What is Leerink Partners's rating on PLRX?
Leerink Partners rates PLRX Market Perform, a neutral rating, as of Mar 3, 2025.
When did Leerink Partners last change its view on PLRX?
On Mar 3, 2025, Leerink Partners downgrades to Market Perform from Outperform.

All Leerink Partners ratingsPLRX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.